According to a recent LinkedIn post from Acclaro Medical, the company is spotlighting its UltraClear Laser-Coring technology through educational content led by its Senior Director of Clinical Excellence, Erin Kazmer. The post describes Laser-Coring as a notable advancement in skin rejuvenation and positions fiber laser as an important future modality in aesthetic treatments.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The company’s LinkedIn post highlights that interested practitioners can access further training and hands-on learning on Acclaro Medical devices via upcoming Acclaro EDGE events in Scottsdale, Ariz., on April 30 and in Boston on May 28. These initiatives suggest an effort to drive practitioner adoption, which could support procedure volume growth, expand device utilization, and potentially strengthen Acclaro Medical’s competitive position in the medical aesthetics equipment market.